Search results for "NATRIURETIC PEPTIDE"

showing 10 items of 178 documents

Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression.

2018

Patients with coronary heart disease (CHD) suffer from physical limitations, but also from psychological distress. Natriuretic peptides may be involved in the neurobiological processes that modulate psychological adaptation, as they are increased in heart disease and seem to have an anxiolytic-like function. Longitudinal data on this association are scarce.To assess the relationship between NT-proBNP and anxiety (Hospital Anxiety and Depression Scale (HADS)), we used secondary data from a multicenter trial from baseline to 24 months. Patients (N = 308, 80.8% male, mean age 60.1 years) had stable CHD and moderate levels of depression (HADS ≥8).Multiple linear regression adjusted for age, sex…

Malemedicine.medical_specialtyHeart diseasemedicine.drug_classDiseaseCoronary Artery DiseaseAnxietyHospital Anxiety and Depression ScaleCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineMulticenter trialNatriuretic Peptide BrainNatriuretic peptideMedicineHumanscardiovascular diseases030212 general & internal medicineLongitudinal StudiesDepression (differential diagnoses)Depressive Disorderbusiness.industryAnxiety ; Coronary Heart Disease ; Depression ; Natriuretic PeptideMiddle Agedmedicine.diseasePeptide FragmentsPsychotherapyPsychiatry and Mental healthClinical PsychologyAnxietyFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryJournal of psychosomatic research
researchProduct

Inflammatory pathways in patients with heart failure and preserved ejection fraction.

2008

Immune activation is well established in patients with chronic heart failure and reduced ejection fraction (HF and reduced EF) and is associated with an impaired prognosis. Patients with heart failure and preserved ejection fraction (HF and preserved EF) have an impaired prognosis as well. It is not known whether they have signs of immune activation.We studied patients with HF and preserved EF (n=17, NYHA II [n=7]/III [n=10]) and patients with HF and reduced EF (n=17 NYHA II [n=1]/III [n=16]) and 20 controls. Echocardiography demonstrated preserved ejection fraction (LVEF 59+/-9%), but LV hypertrophy in patients with preserved EF as compared with patients with reduced EF (LVEF 23+/-5%). We …

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentHemodynamicsInflammationVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineHumansIn patientReceptorAgedAged 80 and overHeart FailureInflammationEjection fractionbusiness.industryStroke VolumeMiddle Agedmedicine.diseasePeptide FragmentsCytokineHeart failureCardiologyCytokinesFemalemedicine.symptomInflammation MediatorsCardiology and Cardiovascular MedicinebusinessSignal TransductionInternational journal of cardiology
researchProduct

Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice

2015

Doxorubicin (DOX) is known to induce serious cardiotoxicity, which is believed to be mediated by oxidative stress and complex interactions with iron. However, the relationship between iron and DOX-induced cardiotoxicity remains controversial and the role of iron chelation therapy to prevent cardiotoxicity is called into question. Firstly, we evaluated in vitro the effects of DOX in combination with dextran-iron on cell viability in cultured H9c2 cardiomyocytes and EMT-6 cancer cells. Secondly, we used an in vivo murine model of iron overloading (IO) in which male C57BL/6 mice received a daily intra-peritoneal injection of dextran-iron (15mg/kg) for 3weeks (D0-D20) and then (D21) a single su…

Malemedicine.medical_specialtyIron OverloadCell SurvivalHeart VentriclesIronCardiomegaly030204 cardiovascular system & hematologyToxicologymedicine.disease_causeCell LineVentricular MyosinsMice03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemAtrial natriuretic peptideIn vivoCell Line TumorInternal medicineNatriuretic Peptide Brainpolycyclic compoundsmedicineAnimalsMyocytes CardiacDoxorubicinViability assay030304 developmental biologyPharmacology0303 health sciencesCardiotoxicityCell growthChemistryDextransBrain natriuretic peptideCardiotoxicity[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemUp-Regulation3. Good healthMice Inbred C57BLOxidative Stresscell proliferationEndocrinologyDoxorubicincardiovascular systemOxidative stressmedicine.drugToxicology and Applied Pharmacology
researchProduct

A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community

2011

Objectives We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. Background The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions. Methods We genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized. Results Genotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associa…

Malemedicine.medical_specialtyLinkage disequilibriumSettore MED/09 - Medicina InternaGenotypemedicine.drug_classPopulationBlood PressureArticlemetabolic syndromeBody Mass IndexRandom AllocationAtrial natriuretic peptideInternal medicineatrial natriuretic peptidelipid metabolismNatriuretic Peptide BrainHomeostasimedicineNatriuretic peptideHomeostasisHumansAlleleeducationAllelesAgedAlleleeducation.field_of_studycardiometabolic diseasebusiness.industryGenetic VariationDNAMiddle Agedmedicine.diseaseEchocardiography DopplerGenotype frequencyProtein Structure TertiaryMinor allele frequencyEndocrinologyPhenotypeFemaleMetabolic syndromebusinessCardiology and Cardiovascular Medicinenatriuretic peptidesAtrial Natriuretic FactorHuman
researchProduct

Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute hea…

2017

Aim: Baseline values of N-terminal pro B-type natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) predict all-cause mortality in acute heart failure (AHF). However, there is limited information about the added prognostic benefit of using longitudinal values, and how this predictive ability is modified when modelling together. The aim of this study was to determine the mutually-adjusted association between the longitudinal trajectories of NT-proBNP and CA125 with all-cause mortality after an episode of AHF. Methods and results: We included 946 consecutive patients discharged for AHF. NT-proBNP and CA125 were measured at each physician-patient encounter (median (interquartile…

Malemedicine.medical_specialtyLongitudinal studyTime Factorsacute heart failuremedicine.drug_class030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineRisk Assessment03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineCause of DeathNatriuretic Peptide BrainmedicineNatriuretic peptideHumans030212 general & internal medicineMortalitycarbohydrate antigen 125Survival rateCause of deathAgedRetrospective StudiesHeart Failurebusiness.industrylongitudinal studyMembrane ProteinsRetrospective cohort studyGeneral MedicineBrain natriuretic peptidemedicine.diseasePrognosisPeptide FragmentsSurvival RateEndocrinologyB-type natriuretic peptideSpainHeart failureCA-125 AntigenAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesEuropean heart journal. Acute cardiovascular care
researchProduct

Prognostic Value of Brain Natriuretic Peptide in Acute Heart Failure: Mortality and Hospital Readmission

2008

The prognostic value of brain natriuretic peptide (BNP) measurement in patients with acute heart failure is not well understood. The aim of this study was to investigate the relationship between the BNP level and mortality and readmission for acute heart failure. We studied 569 consecutive patients who were admitted with a diagnosis of acute heart failure. The BNP level was measured after the patient became clinically stable. The relationship between the BNP level and mortality was assessed by Cox regression analysis, and the relationship with readmission, by competing risks regression analysis. During a median follow-up period of 9 (range, 3-18) months, 156 deaths (27.4%) and 140 readmissi…

Malemedicine.medical_specialtyMultivariate analysismedicine.drug_classPatient ReadmissionInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansIn patientProspective Studiescardiovascular diseasesProspective cohort studyHeart FailureHospital readmissionProportional hazards modelbusiness.industryGeneral MedicineMiddle AgedPrognosisBrain natriuretic peptidemedicine.diseaseHeart failureAcute DiseaseCardiologyFemalebusinesshuman activitieshormones hormone substitutes and hormone antagonistsRevista Española de Cardiología (English Edition)
researchProduct

CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.

2019

In acute heart failure (AHF) with right ventricular dysfunction, the roles of amino-terminal pro-brain natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) are poorly understood, and functional tricuspid regurgitation (TR) severity is thought to indicate a poor prognosis. We examined the prognostic abilities of NT-proBNP and CA125 according to TR status among patients with AHF.TR severity was assessed during index hospitalization (108 ± 24 h after admission) and classified as none/trivial, mild, moderate, or severe. Multivariable Cox regression analysis was performed to assess how pre-discharge CA125 and NT-proBNP were associated with long-term all-cause mortality relative t…

Malemedicine.medical_specialtyMultivariate analysismedicine.drug_classRegurgitation (circulation)030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseases030212 general & internal medicineAgedAged 80 and overHeart FailureEjection fractionProportional hazards modelbusiness.industryMembrane ProteinsStroke VolumeMiddle Agedmedicine.diseasePrognosisPeptide FragmentsTricuspid Valve InsufficiencyHeart failureCA-125 AntigenCardiologyBiomarker (medicine)FemaleCardiology and Cardiovascular MedicineIndex hospitalizationbusinessBiomarkersInternational journal of cardiology
researchProduct

Comparison of N-terminal proB-type natriuretic peptide levels at different stages of visceral leishmaniosis and in patients with chronic kidney disea…

2018

N-terminal proB-type natriuretic peptide (NT-proBNP) may be a useful marker in canine leishmaniosis (CanL). The aim was to compare NT-proBNP in dogs at different LeishVet stages of CanL and with idiopathic chronic kidney disease (CKD). Dogs diagnosed with CanL or CKD and a group of healthy dogs were included (group A, five normal dogs; group B, six dogs LeishVet 1-2; group C, 13 dogs LeishVet 3-4; group D, six dogs with CKD). NT-proBNP was higher (P0.001) in group C (7.616 pmol/l, interquartile range (IQR) 3537-10,000 pmol/l) than in group A (293 pmol/l, IQR 257-373), group B (388.5 pmol/l, IQR 324-793) and group D (740 pmol/l, IQR 557-962 pmol/l). International Renal Interest Society (IRIS…

Malemedicine.medical_specialtyMyocarditisN-Terminal ProB-type Natriuretic Peptide040301 veterinary sciencesmedicine.drug_classLeft ventricular hypertrophyGastroenterologyGroup A0403 veterinary scienceDogsInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideAnimalsHumansIn patientcardiovascular diseasesDog DiseasesRenal Insufficiency ChronicGeneral Veterinarybusiness.industry0402 animal and dairy science04 agricultural and veterinary sciencesGeneral Medicinemedicine.disease040201 dairy & animal sciencePeptide FragmentsLeishmaniasis VisceralFemalebusinesshormones hormone substitutes and hormone antagonistsBiomarkersKidney diseaseThe Veterinary record
researchProduct

Diabetes impairs the atrial natriuretic peptide relaxant action mediated by potassium channels and prostacyclin in the rabbit renal artery.

2012

Diabetes is associated with increased prevalence of hypertension, cardiovascular and renal disease. Atrial natriuretic peptide (ANP) plays an important role in cardiovascular pathophysiology and is claimed to have cardioprotective and renoprotective effect in diabetic patients. The working hypothesis was that alloxan-induced diabetes might modify the vascular effects of ANP in isolated rabbit renal arteries and the mechanisms involved in such actions. Plasma ANP levels were higher in diabetic rabbits than in control rabbits. ANP (10(-12)-10(-7)M) induced a relaxation of precontracted renal arteries, which was lower in diabetic than in control rabbits. In arteries from both groups of animals…

Malemedicine.medical_specialtyPotassium ChannelsEndotheliumProstacyclinIn Vitro TechniquesDiabetes Mellitus ExperimentalGlibenclamideThromboxane A2chemistry.chemical_compoundThromboxane A2Renal ArteryAtrial natriuretic peptidemedicine.arteryDiabetes mellitusInternal medicinemedicineAnimalsRenal arteryPharmacologybusiness.industryTetraethylammoniummedicine.diseaseEpoprostenolPotassium channelVasodilationEndocrinologymedicine.anatomical_structurechemistrycardiovascular systemEndothelium VascularRabbitsbusinesshormones hormone substitutes and hormone antagonistsAtrial Natriuretic Factorcirculatory and respiratory physiologymedicine.drugPharmacological research
researchProduct

B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.

2008

In early stages of septic shock, impaired myocardial function plays an important prognostic role. In this context, B-type natriuretic peptide (BNP) has been shown to be a neurohumoral marker for left ventricular dysfunction, because myocardial strain and ischemia both increase BNP concentration. The present study was designed to test if BNP allows for identification of patients at risk for developing sepsis-induced myocardial depression and if an increased concentration of BNP is associated with an adverse outcome in patients with septic shock.In a prospective study, 93 patients with septic shock were divided into one group with normal ventricular function (left ventricular ejection fractio…

Malemedicine.medical_specialtyResuscitationCritical Caremedicine.drug_classIschemiaContext (language use)Critical Care and Intensive Care MedicineSepsisVentricular Dysfunction LeftInternal medicineIntensive careSepsisNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseasesProspective StudiesIntensive care medicineAgedSeptic shockbusiness.industryModels CardiovascularMiddle Agedmedicine.diseasePrognosisShock SepticROC CurveShock (circulatory)Multivariate Analysiscardiovascular systemCardiologyFemalemedicine.symptombusinesshuman activitieshormones hormone substitutes and hormone antagonistsBiomarkersCritical care medicine
researchProduct